Mechanistic Insights in NeuroD Potentiation of Mineralocorticoid Receptor Signaling.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
29 Mar 2019
Historique:
received: 01 03 2019
revised: 24 03 2019
accepted: 25 03 2019
entrez: 3 4 2019
pubmed: 3 4 2019
medline: 23 7 2019
Statut: epublish

Résumé

Mineralocorticoid receptor (MR)-mediated signaling in the brain has been suggested as a protective factor in the development of psychopathology, in particular mood disorders. We recently identified genomic loci at which either MR or the closely related glucocorticoid receptor (GR) binds selectively, and found members of the NeuroD transcription factor family to be specifically associated with MR-bound DNA in the rat hippocampus. We show here using forebrain-specific MR knockout mice that GR binding to MR/GR joint target loci is not affected in any major way in the absence of MR. Neurod2 binding was also independent of MR binding. Moreover, functional comparison with MyoD family members indicates that it is the chromatin remodeling aspect of NeuroD, rather than its direct stimulation of transcription, that is responsible for potentiation of MR-mediated transcription. These findings suggest that NeuroD acts in a permissive way to enhance MR-mediated transcription, and they argue against competition for DNA binding as a mechanism of MR- over GR-specific binding.

Identifiants

pubmed: 30934833
pii: ijms20071575
doi: 10.3390/ijms20071575
pmc: PMC6479562
pii:
doi:

Substances chimiques

Basic Helix-Loop-Helix Transcription Factors 0
MyoD Protein 0
Nerve Tissue Proteins 0
Receptors, Glucocorticoid 0
Receptors, Mineralocorticoid 0
Neurogenic differentiation factor 1 169238-82-8
DNA 9007-49-2
Corticosterone W980KJ009P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek
ID : 823.02.002

Références

Mol Pharmacol. 2009 Dec;76(6):1360-9
pubmed: 19786558
Nature. 2019 Sep;573(7772):61-68
pubmed: 31435019
J Psychiatr Res. 2010 Apr;44(6):339-46
pubmed: 19909979
Biol Psychiatry. 2006 Dec 15;60(12):1343-9
pubmed: 16889757
J Control Release. 2018 Sep 28;286:210-223
pubmed: 29964136
Dev Cell. 2012 Apr 17;22(4):721-35
pubmed: 22445365
Cell. 2011 Aug 19;146(4):544-54
pubmed: 21835447
Neuropsychopharmacology. 2015 Jan;40(2):386-93
pubmed: 25035081
Genes Dev. 2019 Jan 1;33(1-2):6-25
pubmed: 30602438
Nat Commun. 2019 Jan 18;10(1):306
pubmed: 30659202
Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):195-200
pubmed: 16368758
Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11336-11341
pubmed: 27655894
Front Neuroendocrinol. 2009 Aug;30(3):328-42
pubmed: 19401208
J Biol Chem. 2017 Apr 7;292(14):5825-5844
pubmed: 28223352
Psychoneuroendocrinology. 2011 May;36(4):484-94
pubmed: 20884124
Mol Cell. 2016 Nov 3;64(3):624-635
pubmed: 27773674
Front Physiol. 2018 Feb 05;9:13
pubmed: 29459828
J Clin Oncol. 2016 Jul 1;34(19):2287-93
pubmed: 27161966
Gene Ther. 2007 Aug;14(15):1152-9
pubmed: 17525703
Endocrinology. 2017 May 1;158(5):1511-1522
pubmed: 28324065
Nat Rev Neurosci. 2005 Jun;6(6):463-75
pubmed: 15891777
Nat Med. 2017 Sep;23(9):1102-1111
pubmed: 28825715
J Neuroendocrinol. 2019 Aug;31(8):e12735
pubmed: 31121060
BMC Neurosci. 2012 Oct 03;13:118
pubmed: 23031785
Transl Psychiatry. 2011 Dec 13;1:e62
pubmed: 22832354
Am J Psychiatry. 2014 Oct;171(10):1045-51
pubmed: 25272344
Endocrinology. 1985 Dec;117(6):2505-11
pubmed: 2998738
Cell Rep. 2015 Mar 31;10(12):1937-46
pubmed: 25801030
Transl Psychiatry. 2014 Nov 25;4:e485
pubmed: 25423137
Neuron. 2016 Jun 1;90(5):969-83
pubmed: 27181059
Science. 1993 Feb 19;259(5098):1161-5
pubmed: 8382376
J Neuroendocrinol. 2016 Aug;28(8):
pubmed: 26970338
Endocrinology. 2017 May 1;158(5):1486-1501
pubmed: 28200020
Dev Cell. 2016 Feb 22;36(4):375-85
pubmed: 26906734
EMBO J. 2016 Jan 4;35(1):24-45
pubmed: 26516211
Mol Endocrinol. 2005 Sep;19(9):2245-57
pubmed: 15919722

Auteurs

Lisa T C M van Weert (LTCM)

Department of Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. L.T.C.M.van_Weert@lumc.nl.
Department of Cognitive Neuroscience, Radboudumc, 6525 GA Nijmegen, The Netherlands. L.T.C.M.van_Weert@lumc.nl.
Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 EN Nijmegen, The Netherlands. L.T.C.M.van_Weert@lumc.nl.

Jacobus C Buurstede (JC)

Department of Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. J.C.Buurstede@lumc.nl.

Hetty C M Sips (HCM)

Department of Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. H.C.M.Sips@lumc.nl.

Isabel M Mol (IM)

Department of Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. I.M.Mol@lumc.nl.

Tanvi Puri (T)

Department of Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. tanvi-04@hotmail.com.

Ruth Damsteegt (R)

Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands. R.Damsteegt@umcutrecht.nl.

Benno Roozendaal (B)

Department of Cognitive Neuroscience, Radboudumc, 6525 GA Nijmegen, The Netherlands. Benno.Roozendaal@radboudumc.nl.
Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 EN Nijmegen, The Netherlands. Benno.Roozendaal@radboudumc.nl.

R Angela Sarabdjitsingh (RA)

Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands. r.a.sarabdjitsingh@gmail.com.

Onno C Meijer (OC)

Department of Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. O.C.Meijer@lumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH